老年脓毒性休克最佳目标血压(OPTPRESS)试验:随机对照试验研究方案
本研究为多中心、实用性、单盲随机对照试验,在日本28家医院比较老年脓毒性休克患者复苏时高目标平均动脉压80-85 mmHg与对照65-70 mmHg的疗效。主要结局为随机化后90天全因死亡率,目标血压维持72小时或直至不再需要血管升压药。
要点
- 老年脓毒性休克患者随机分为高目标平均动脉压80-85 mmHg组与对照65-70 mmHg组。
- 目标平均动脉压维持72小时或直至不再需要血管升压药以改善病情。
- 主要结局为随机化后90天全因死亡率。
核心结论
- 该试验结果将为全球老龄化社会中的脓毒性休克复苏策略提供重要见解,并增进对危重症患者血流动力学管理中个体化治疗策略重要性的理解。
研究设计与样本
- 多中心、实用性、单盲随机对照试验,在日本28家医院开展,纳入年龄≥65岁的脓毒性休克患者,随机分配至高目标组或对照组。
主要发现
- 原文未报告结果。
关键数值与推荐
- 高目标组平均动脉压目标为80-85 mmHg,对照组为65-70 mmHg。
- 目标平均动脉压维持72小时或直至不再需要血管升压药以改善病情。
- 若维持目标平均动脉压需要去甲肾上腺素剂量≥0.1 μg/kg/min,则启动血管加压素。
临床怎么用
- 液体管理、氢化可的松使用和抗生素选择由主管医生根据最新临床指南决定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemodynamic stabilization is a core component in the resuscitation of septic shock. However, the optimal target blood pressure remains debatable. Previous randomized controlled trials suggested that uniformly adopting a target mean arterial pressure (MAP) higher than 65 mmHg for all adult septic shock patients would not be beneficial; however, it has also been proposed that higher target MAP may be beneficial for elderly patients, especially those with arteriosclerosis. METHODS: A multicenter, pragmatic single-blind randomized controlled trial will be conducted to compare target MAP of 80-85 mmHg (high-target) and 65-70 mmHg (control) in the resuscitation of septic shock patients admitted to 28 hospitals in Japan. Patients with septic shock aged ≥65 years are randomly assigned to the high-target or control groups. The target MAP shall be maintained for 72 h after randomization or until vasopressors are no longer needed to improve patients' condition. To minimize the adverse effects related to catecholamines, if norepinephrine dose of ≥ 0.1 μg/kg/min is needed to maintain the target MAP, vasopressin will be initiated. Other therapeutic approaches, including fluid administration, hydrocortisone use, and antibiotic choice, will be determined by the physician in charge based on the latest clinical guidelines. The primary outcome is all-cause mortality at 90 days after randomization. DISCUSSION: The result of this trial will provide great insight on the resuscitation strategy for septic shock in the era of global aged society. Also, it will provide the better understanding on the importance of individualized treatment strategy in hemodynamic management in critically ill patients. TRIAL REGISTRATION: UMIN Clinical Trials Registry; UMIN000041775. Registered 13 September 2020.
引用
- Endo A, Yamakawa K, Tagami T, et al. Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial. Trials. 2022. PMID: 36153530. doi:10.1186/s13063-022-06732-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。